搜全站

15121004110

上海允麥生物科技有限公司
中級會員 | 第7年
USP28抗原，泛素特異性蛋白酶28抗原2024/12/26
RecombinanthumanUSP28Deubiquitinatingenzyme28;KIAA1515;Ubiquitincarboxylterminalhydrolase28;Ubiquitincarboxyl-terminalhydrolase28;Ubiquitinspecificpeptidase28;Ubiquitinspecificprocessingprotease28;Ubiquitinspecificprotease28;Ubiquitinthioesterase28;U
USP3抗原，去泛素化酶3抗原2024/12/26
RecombinanthumanUSP3Deubiquitinatingenzyme3;EC3.1.2.15;SIH003;Ubiquitincarboxyl-terminalhydrolase3;Ubiquitinspecificpeptidase3;Ubiquitinspecificprocessingprotease3;UbiquitinSpecificProtease3;Ubiquitinthioesterase3;Ubiquitinthiolesterase3;Ubiquitin-sp
USP50抗原，泛素特異性蛋白酶50抗原2024/12/26
RecombinanthumanUSP50Inactiveubiquitincarboxyl-terminalhydrolase50Inactiveubiquitinspecificpeptidase50;Ubiquitinspecificpeptidase50;UBP50_HUMAN;Ubiquitinspecificprotease50;USP50.濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Escherichiacoli標(biāo)簽：Histag
USP9X抗原，泛素特異性蛋白酶9X抗原2024/12/26
RecombinanthumanUSP9XXchromosome;X-linked;DeubiquitinatingenzymeFAFX;DeubiquitinatingenzymeFAF-X;DFFRX;Fafl;Fam;Fatfacetshomolog;Fatfacetsinmammals;FatfacetsproteinrelatedXlinked;FatfacetsproteinrelatedX-linked;Fatfacetsprotein-related;hFAM;Probableu
Uteroglobin抗原，子宮珠蛋白抗原2024/12/26
RecombinanthumanUteroglobinClaracellprotein16;SCGB1A1;CC10;CCPBP;CCSP;UGB;UP-1;UP1;Secretoglobin,family1A,member1;PCB-bindingprotein;PCB-BP;UG;Claracellphospholipid-binding;CC16;Claracells10kDasecretoryprotein;Urinaryprotein1;Urineprotein1;UTER_HUMAN
VAMP1抗原，VAMP1囊泡相關(guān)膜蛋白1抗原2024/12/18
RecombinanthumanVAMP1VesicleAssociatedMembraneProtein1;DKFZp686H12131;SYB1;SYB1;Synaptobrevin1;Synaptobrevin1;Synaptobrevin-1;VAMP1;VAMP-1;Vesicleassociatedmembraneprotein1;Vesicleassociatedmembraneprotein1synaptobrevin1;VAMP1_HUMAN;Vesicle-associate
VAMP-1+2+3抗原，囊泡相關(guān)膜蛋白1,2,3抗原2024/12/18
RecombinanthumanVAMP-1+2+3VAMP-1+2+3;VesicleAssociatedMembraneProtein1;DKFZp686H12131;SYB1;SYB1;Synaptobrevin1;Synaptobrevin1;Synaptobrevin-1;VAMP1;VAMP-1;Vesicleassociatedmembraneprotein1;Vesicleassociatedmembraneprotein1synaptobrevin1;VAMP1_HUMAN;V
valyl tRNA抗原，纈氨酰-tRNA合成酶抗原2024/12/18
RecombinanthumanvalyltRNASYVM_HUMAN;Valine--tRNAligase,mitochondrial;Valyl-tRNAsynthetase;ValRS;Valyl-tRNAsynthetase-like;valyltRNA;VARS2;KIAA1885;VARS2L;VARSL.濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Escherichiacoli標(biāo)簽：Histag蛋白長度：Fulllengthpro
V5 tag抗原，V5 tag標(biāo)簽抗原2024/12/18
RecombinanthumanV5tagV5-tag;GKPIPNPLLGLDSTepitopetag;GKPIPNPLLGLDSTtag;ProteinRev;Regulatorofexpressionofviralproteins;rev;V5epitopetag.濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Escherichiacoli標(biāo)簽：Histag蛋白長度：Fulllengthprotein內(nèi)毒素水平：純化方法：HPLC應(yīng)用：SD
VAPB抗原，囊泡相關(guān)膜蛋白相關(guān)的蛋白B抗原2024/12/11
RecombinanthumanVAPBALS8;ALS8;D2Abb2e;UNQ484/PRO983;Vamp33b;VAMPassociated33kDaprotein;VAMPassociatedproteinBａndC;VAMPassociatedproteinB;VAMPassociatedproteinB/C;VAMPassociatedproteinC;VAMPB;VAMPBVAMPC;VAMPB/VAMPC;VAMPC;VAMPvesicleassociatedmembranep
VASH1抗原，血管抑制蛋白1抗原2024/12/11
RecombinanthumanVASH1Vasohibin;KIAA1036;VASH;VASH;VASH1;VASH1_HUMAN;Vasohibin1;Vasohibin-1濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Wheatgerm標(biāo)簽：GSTtagN-Terminus蛋白長度：Fulllengthprotein內(nèi)毒素水平：純化方法：HPLC應(yīng)用：SDS-PAGE，Westernblot，ELISABiologicalactivity
Vasopressin抗原，抗利尿激素/血管升壓素/加壓素/血管加壓素抗原2024/12/11
RecombinanthumanVasopressinVasopressin;AntidiureticHormone;ArginineVasopressin;ADH;ArgininevasopressinneurophysinII;ARVP;AVP;AVPNPII;AVRP;Vasopressinneurophysin2copeptinprecursor;VasopressinneurophysinIIcopeptin;NEU2_HUMAN;VP.濃度：1mg/ml來源：RecombinantH
VASP抗原，血管擴(kuò)張刺激磷蛋白抗原2024/12/11
RecombinanthumanVASPVasodilatorstimulatedphosphoprotein；Vasodilator-stimulatedphosphoprotein；VASP；VASP_HUMAN.濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Escherichiacoli標(biāo)簽：Histag蛋白長度：Fulllengthprotein內(nèi)毒素水平：純化方法：HPLC應(yīng)用：SDS-PAGE，Westernblot，ELISABio
VAT1L抗原，囊泡胺轉(zhuǎn)運蛋白1家族蛋白抗原2024/12/11
RecombinanthumanVAT1LVAT1L_HUMAN;SynapticvesiclemembraneproteinVAT-1homolog-like;EC:1.-.-.-;KIAA1576;vesicleaminetransport1like;濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Escherichiacoli標(biāo)簽：Histag蛋白長度：Fulllengthprotein內(nèi)毒素水平：純化方法：HPLC應(yīng)用：SDS-PAGE，W
VAV3抗原，鳥嘌呤核苷酸交換因子VAV3抗原2024/12/04
RecombinanthumanVAV3GuaninenucleotideexchangefactorVAV3;Proteinvav3;Proteinvav3;VAV3;Vav3guaninenucleotideexchangefactor;VAV3oncogene;VAV3protein;VAV-3;VAV3oncogene;VAV3protein;VAV3_HUMAN.濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Escherichiacol
VAV2抗原，癌基因VAV2抗原2024/12/04
RecombinanthumanVAV2OncogeneVAV2;Proteinvav2;VAV2;Vav2oncogene;VAV2oncogene;VAV2_HUMAN濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Escherichiacoli標(biāo)簽：Histag蛋白長度：Fulllengthprotein內(nèi)毒素水平：純化方法：HPLC應(yīng)用：SDS-PAGE，Westernblot，ELISABiologicalactivity,immunol
VAV1抗原，鳥苷酸轉(zhuǎn)換因子VAV1抗原2024/12/04
RecombinanthumanVAV1Oncogenevav;p95Vav;Protooncogenevav;Proto-oncogenevav;VAV1;VAV1oncogene;VAV;Vavprotooncogene;Vavproto-oncogene;VAV_HUMAN.濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Escherichiacoli標(biāo)簽：HistagN-Terminus蛋白長度：Fulllengthprotein內(nèi)毒素水平
V-ATPase A1抗原，氫離子轉(zhuǎn)運ATP合成酶A1抗原2024/12/04
RecombinanthumanVAV3GuaninenucleotideexchangefactorVAV3;Proteinvav3;Proteinvav3;VAV3;Vav3guaninenucleotideexchangefactor;VAV3oncogene;VAV3protein;VAV-3;VAV3oncogene;VAV3protein;VAV3_HUMAN.濃度：1mg/ml來源：RecombinantHuman純度：≥95%SDS-PAGE表達(dá)系統(tǒng)：Escherichiacol
VAT1抗原，嗜鉻顆粒胺轉(zhuǎn)運蛋白VAT1抗原2024/12/04
RecombinanthumanVAT1VAT1antibody,FLJ20230antibody,Membraneproteinofcholinergicsynapticvesiclesantibody,MGC124668antibody,OTTMUSP00000002784antibody,RP23-328K2.5antibody,SynapticvesiclemembraneproteinVAT1homologantibody,SynapticvesiclemembraneproteinV
VDAC抗原，等電壓依賴性陰離子通道抗原2024/12/03
RecombinanthumanVDACvoltage-dependentanionchannel;hVDAC1;MGC111064;Outermitochondrialmembraneproteinporin1;Plasmalemmalporin;Porin31HL;Porin31HL;Porin31HM;VDAC1;VDAC;VDAC1;Voltagedependentanionchannel1;Voltagedependentanionselectivechannelprotein1;VD
12345共10頁194條記錄